Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleic acid synthesis in *Plasmodium* refers to the processes by which the malaria parasite synthesizes DNA and RNA, essential for its replication and survival during its complex life cycle. This process is a critical target for antimalarial drug development because it is indispensable for parasite proliferation within human red blood cells. The parasite relies on both purine salvage pathways and de novo pyrimidine biosynthesis for nucleic acid production. Key enzymes involved include DNA polymerases, primase, helicase, and exonucleases. The apicoplast organelle contains unique machinery that is essential for organellar genome maintenance, making it an attractive drug target.
Inhibition of nucleotide biosynthesis, inhibition of polymerases, inhibition of exonucleases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleic Acid Synthesis (Plasmodium).